ALLOCETRA Trademark

Trademark Overview

On Wednesday, September 26, 2018, a trademark application was filed for ALLOCETRA with the United States Patent and Trademark Office. The USPTO has given the ALLOCETRA trademark a serial number of 88133420. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 23, 2022. This trademark is owned by Enlivex Therapeutics Ltd. The ALLOCETRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases
allocetra

General Information

Serial Number88133420
Word MarkALLOCETRA
Filing DateWednesday, September 26, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 23, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune and inflammatory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEnlivex Therapeutics Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91120
IL
Party NameEnlivex Therapeutics Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91120
IL

Trademark Events

Event DateEvent Description
Monday, May 23, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 23, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 5, 2021SOU EXTENSION 5 GRANTED
Thursday, September 30, 2021SOU EXTENSION 5 FILED
Tuesday, October 5, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 30, 2021TEAS EXTENSION RECEIVED
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021SOU EXTENSION 4 GRANTED
Thursday, April 15, 2021SOU EXTENSION 4 FILED
Thursday, April 15, 2021TEAS EXTENSION RECEIVED
Wednesday, October 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 5, 2020SOU EXTENSION 3 GRANTED
Monday, October 5, 2020SOU EXTENSION 3 FILED
Monday, October 5, 2020TEAS EXTENSION RECEIVED
Saturday, April 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 2, 2020SOU EXTENSION 2 GRANTED
Thursday, April 2, 2020SOU EXTENSION 2 FILED
Thursday, April 2, 2020TEAS EXTENSION RECEIVED
Saturday, October 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2019SOU EXTENSION 1 GRANTED
Thursday, October 3, 2019SOU EXTENSION 1 FILED
Thursday, October 3, 2019TEAS EXTENSION RECEIVED
Tuesday, April 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 8, 2019ASSIGNED TO EXAMINER
Thursday, October 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 29, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

allocetra inflammatory diseases autoimmune treatment preparations pharmaceutical